Jan 052018
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CO – miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today that it has appointed biotechnology industry veteran Arlene Morris to the role of independent board member on its Board of Directors, effective January 3, 2018.… => Read Full post

miRagen Therapeutics added Arlene Morris to the Board as Independent Director

From:: miRagen Therapeutics added Arlene Morris to the Board as Independent Director

Sorry, the comment form is closed at this time.

%d bloggers like this: